PDF herunterladen
Am J Perinatol 2014; 31(07): 629-636
DOI: 10.1055/s-0034-1383884
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Percutaneous Fetal Cardiac Interventions for Structural Heart Disease

David N. Schidlow
1   Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts
2   Department of Pediatrics, Harvard Medical School, Boston, Massachusetts
,
Wayne Tworetzky
1   Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts
2   Department of Pediatrics, Harvard Medical School, Boston, Massachusetts
,
Louise E. Wilkins-Haug
3   Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
› Institutsangaben
Weitere Informationen

Publikationsverlauf

15. November 2013

16. Februar 2014

Publikationsdatum:
12. Juni 2014 (online)

    Lizenzen und Reprints

Abstract

Introduction Prenatal diagnosis provides valuable information regarding a variety of congenital heart defects. Some defects occur early in gestation with little change throughout pregnancy, whereas others evolve during mid and late gestation. Fetal cardiac intervention (FCI) affords the opportunity to interrupt progression of disease in this latter category, resulting in improved perinatal and lifelong outcomes.

Aim This chapter addresses three lesions for which percutaneous FCI can be utilized: (1) aortic stenosis with evolving hypoplastic left heart syndrome, for which aortic valvuloplasty may prevent left ventricular hypoplasia and has yielded a biventricular circulation in approximately one third of cases; (2) hypoplastic left heart syndrome with intact atrial septum, for which relief of atrial restriction has potential to improve perinatal survival; and (3) pulmonary atresia with intact ventricular septum and evolving right ventricular hypoplasia, for which pulmonary valvuloplasty has resulted in a biventricular circulation in the majority of patients. The pathophysiology, rationale for intervention, patient selection criteria, procedural technique, and outcomes for each lesion will be reviewed. This chapter will also review complications of FCI and their treatment, and maternal and fetal anesthesia specific to FCI. The importance of a specialized center with experience managing infants delivered after FCI will also be addressed.

Keywords

congenital heart disease - fetal cardiac intervention - aortic stenosis - hypoplastic left heart syndrome - pulmonary atresia with intact ventricular septum
 

  • References

  • 1 Maxwell D, Allan L, Tynan MJ. Balloon dilatation of the aortic valve in the fetus: a report of two cases. Br Heart J 1991; 65 (5) 256-258
    CrossrefPubMedGoogle Scholar
  • 2 Mäkikallio K, McElhinney DB, Levine JC , et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation 2006; 113 (11) 1401-1405
    CrossrefPubMedGoogle Scholar
  • 3 Simpson JM, Sharland GK. Natural history and outcome of aortic stenosis diagnosed prenatally. Heart 1997; 77 (3) 205-210
    CrossrefPubMedGoogle Scholar
  • 4 Karamlou T, Diggs BS, Ungerleider RM, Welke KF. Evolution of treatment options and outcomes for hypoplastic left heart syndrome over an 18-year period. J Thorac Cardiovasc Surg 2010; 139 (1) 119-126 , discussion 126–127
    CrossrefPubMedGoogle Scholar
  • 5 Schidlow DN, Anderson JB, Klitzner TS , et al; JCCHD National Pediatric Cardiology Quality Improvement Collaborative. Variation in interstage outpatient care after the Norwood procedure: a report from the Joint Council on Congenital Heart Disease National Quality Improvement Collaborative. Congenit Heart Dis 2011; 6 (2) 98-107
    CrossrefPubMedGoogle Scholar
  • 6 Burkhart HM, Dearani JA, Mair DD , et al. The modified Fontan procedure: early and late results in 132 adult patients. J Thorac Cardiovasc Surg 2003; 125 (6) 1252-1259
    CrossrefPubMedGoogle Scholar
  • 7 Mair DD, Puga FJ, Danielson GK. The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients. J Am Coll Cardiol 2001; 37 (3) 933-939
    CrossrefPubMedGoogle Scholar
  • 8 Goldberg DJ, Shaddy RE, Ravishankar C, Rychik J. The failing Fontan: etiology, diagnosis and management. Expert Rev Cardiovasc Ther 2011; 9 (6) 785-793
    CrossrefPubMedGoogle Scholar
  • 9 McElhinney DB, Tworetzky W, Lock JE. Current status of fetal cardiac intervention. Circulation 2010; 121 (10) 1256-1263
    CrossrefPubMedGoogle Scholar
  • 10 Wilkins-Haug LE, Tworetzky W, Benson CB, Marshall AC, Jennings RW, Lock JE. Factors affecting technical success of fetal aortic valve dilation. Ultrasound Obstet Gynecol 2006; 28 (1) 47-52
    CrossrefPubMedGoogle Scholar
  • 11 Tworetzky W, Marshall AC. Balloon valvuloplasty for congenital heart disease in the fetus. Clin Perinatol 2003; 30 (3) 541-550
    CrossrefPubMedGoogle Scholar
  • 12 Tworetzky W, Marshall AC. Fetal interventions for cardiac defects. Pediatr Clin North Am 2004; 51 (6) 1503-1513 , vii
    CrossrefPubMedGoogle Scholar
  • 13 McElhinney DB, Vogel M, Benson CB , et al. Assessment of left ventricular endocardial fibroelastosis in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome. Am J Cardiol 2010; 106 (12) 1792-1797
    CrossrefPubMedGoogle Scholar
  • 14 Friedman KG, Margossian R, Graham DA , et al. Postnatal left ventricular diastolic function after fetal aortic valvuloplasty. Am J Cardiol 2011; 108 (4) 556-560
    CrossrefPubMedGoogle Scholar
  • 15 McElhinney DB, Marshall AC, Wilkins-Haug LE , et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation 2009; 120 (15) 1482-1490
    CrossrefPubMedGoogle Scholar
  • 16 Rychik J, Rome JJ, Collins MH, DeCampli WM, Spray TL. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol 1999; 34 (2) 554-560
    CrossrefPubMedGoogle Scholar
  • 17 Forbess JM, Cook N, Roth SJ, Serraf A, Mayer Jr JE, Jonas RA. Ten-year institutional experience with palliative surgery for hypoplastic left heart syndrome. Risk factors related to stage I mortality. Circulation 1995; ; 92 (9) II262-II266
    PubMedGoogle Scholar
  • 18 Forbess JM. Pre-stage II mortality after the Norwood operation: addressing the next challenge. J Thorac Cardiovasc Surg 2003; 126 (5) 1257-1258
    CrossrefPubMedGoogle Scholar
  • 19 Vlahos AP, Lock JE, McElhinney DB, van der Velde ME. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation 2004; 109 (19) 2326-2330
    CrossrefPubMedGoogle Scholar
  • 20 Atz AM, Feinstein JA, Jonas RA, Perry SB, Wessel DL. Preoperative management of pulmonary venous hypertension in hypoplastic left heart syndrome with restrictive atrial septal defect. Am J Cardiol 1999; 83 (8) 1224-1228
    CrossrefPubMedGoogle Scholar
  • 21 Taketazu M, Barrea C, Smallhorn JF, Wilson GJ, Hornberger LK. Intrauterine pulmonary venous flow and restrictive foramen ovale in fetal hypoplastic left heart syndrome. J Am Coll Cardiol 2004; 43 (10) 1902-1907
    CrossrefPubMedGoogle Scholar
  • 22 Michelfelder E, Gomez C, Border W, Gottliebson W, Franklin C. Predictive value of fetal pulmonary venous flow patterns in identifying the need for atrial septoplasty in the newborn with hypoplastic left ventricle. Circulation 2005; 112 (19) 2974-2979
    PubMedGoogle Scholar
  • 23 Glatz JA, Tabbutt S, Gaynor JW , et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg 2007; 84 (5) 1633-1638
    CrossrefPubMedGoogle Scholar
  • 24 Marshall AC, Levine J, Morash D , et al. Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome. Prenat Diagn 2008; 28 (11) 1023-1028
    CrossrefPubMedGoogle Scholar
  • 25 Sandor GG, Cook AC, Sharland GK, Ho SY, Potts JE, Anderson RH. Coronary arterial abnormalities in pulmonary atresia with intact ventricular septum diagnosed during fetal life. Cardiol Young 2002; 12 (5) 436-444
    CrossrefPubMedGoogle Scholar
  • 26 Selamet SE, Hsu DT, Thaker HM, Gersony WM. Complete atresia of coronary ostia in pulmonary atresia and intact ventricular septum. Pediatr Cardiol 2004; 25 (1) 67-69
    CrossrefPubMedGoogle Scholar
  • 27 Kipps AK, Powell AJ, Levine JC. Muscular infundibular atresia is associated with coronary ostial atresia in pulmonary atresia with intact ventricular septum. Congenit Heart Dis 2011; 6 (5) 444-450
    CrossrefPubMedGoogle Scholar
  • 28 Wald RM, Juraszek AL, Pigula FA, Geva T. Echocardiographic diagnosis and management of bilateral coronary ostial atresia in a patient with pulmonary atresia and intact ventricular septum. J Am Soc Echocardiogr 2006; 19 (7) e1-e3
    CrossrefPubMedGoogle Scholar
  • 29 Tworetzky W, McElhinney DB, Marx GR , et al. In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes. Pediatrics 2009; 124 (3) e510-e518
    CrossrefPubMedGoogle Scholar
  • 30 Pedra SR, Peralta CF, Crema L, Jatene IB, da Costa RN, Pedra CA. Fetal interventions for congenital heart disease in Brazil. Pediatr Cardiol 2014; 35 (3) 399-405
    CrossrefPubMedGoogle Scholar
  • 31 Tulzer G, Arzt W, Franklin RC, Loughna PV, Mair R, Gardiner HM. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet 2002; 360 (9345) 1567-1568
    CrossrefPubMedGoogle Scholar
  • 32 Galindo A, Gutiérrez-Larraya F, Velasco JM, de la Fuente P. Pulmonary balloon valvuloplasty in a fetus with critical pulmonary stenosis/atresia with intact ventricular septum and heart failure. Fetal Diagn Ther 2006; 21 (1) 100-104
    CrossrefPubMedGoogle Scholar
  • 33 Arzt W, Tulzer G, Aigner M, Mair R, Hafner E. Invasive intrauterine treatment of pulmonary atresia/intact ventricular septum with heart failure. Ultrasound Obstet Gynecol 2003; 21 (2) 186-188
    CrossrefPubMedGoogle Scholar
  • 34 Mizrahi-Arnaud A, Tworetzky W, Bulich LA , et al. Pathophysiology, management, and outcomes of fetal hemodynamic instability during prenatal cardiac intervention. Pediatr Res 2007; 62 (3) 325-330
    CrossrefPubMedGoogle Scholar
  • 35 Brusseau R, Mizrahi-Arnaud A. Fetal anesthesia and pain management for intrauterine therapy. Clin Perinatol 2013; 40 (3) 429-442
    CrossrefPubMedGoogle Scholar
  • 36 Tworetzky W, Wilkins-Haug L, Jennings RW , et al. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation 2004; 110 (15) 2125-2131
    CrossrefPubMedGoogle Scholar
  • 37 McElhinney DB, Benson CB, Brown DW , et al. Cerebral blood flow characteristics and biometry in fetuses undergoing prenatal intervention for aortic stenosis with evolving hypoplastic left heart syndrome. Ultrasound Med Biol 2010; 36 (1) 29-37
    CrossrefPubMedGoogle Scholar